Evidence map›Paper›PMID 26351520›Full record

ArticleEpigenetics & chromatin2015

Affinity-seq detects genome-wide PRDM9 binding sites and reveals the impact of prior chromatin modifications on mammalian recombination hotspot usage.

Michael Walker, Timothy Billings, Christopher L Baker, Natalie Powers, Hui Tian, Ruth L Saxl, Kwangbom Choi, Matthew A Hibbs, Gregory W Carter, Mary Ann Handel and 2 more

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Footprint-seq: a simple method to quantitatively mapbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. A pedigree-based map of crossovers and non-crossovers in aye-ayes (bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cataloging HumanFrontiers in cell and developmental biology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Michael Walker *Center for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Timothy Billings *Center for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Christopher L BakerCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Natalie PowersCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Hui TianCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Ruth L SaxlCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Kwangbom ChoiCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Matthew A HibbsCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Gregory W CarterCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Mary Ann HandelCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Kenneth PaigenCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.
Petko M PetkovCenter for Genome Dynamics, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609 USA.ORCID 0000-0002-6694-9150
Jackson Laboratory · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
UNC and PERLEGEN, IncP50GM076468 · NIGMS · JACKSON LABORATORY · PI PETKOV, PETKO M · 2006 to 2015
$31.0M
PRDM9 and Meiotic Regulatory NetworksP01GM099640 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2013 to 2017
$8.2M
Sex-Specific Regulation of Meiotic Recombination HotspotsR01GM078452 · NIGMS · JACKSON LABORATORY · PI PETKOV, PETKO M · 2007 to 2015
$3.3M
Genomic Organization of Recombination Hot SpotsR01GM078643 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2006 to 2014
$2.7M
REPRODUCTIVE BIOLOGYT32HD007065 · NICHD · JACKSON LABORATORY · PI BRAUN, ROBERT E · 1985 to 2020
$2.6M
Transacting Genes Regulating Recombination Hotspot ActivitiesR01GM083408 · NIGMS · JACKSON LABORATORY · PI PAIGEN, KENNETH · 2008 to 2014
$2.2M
NCI NIH HHS P30 CA034196NICHD NIH HHS T32 HD007065NIGMS NIH HHS P01 GM099640NIGMS NIH HHS P50 GM076468NIGMS NIH HHS R01 GM078452NIGMS NIH HHS R01 GM078643NIGMS NIH HHS R01 GM083408
6 · The paper itself

Abstract

backgroundGenetic recombination plays an important role in evolution, facilitating the creation of new, favorable combinations of alleles and the removal of deleterious mutations by unlinking them from surrounding sequences. In most mammals, the placement of genetic crossovers is determined by the binding of PRDM9, a highly polymorphic protein with a long zinc finger array, to its cognate binding sites. It is one of over 800 genes encoding proteins with zinc finger domains in the human genome.

resultsWe report a novel technique, Affinity-seq, that for the first time identifies both the genome-wide binding sites of DNA-binding proteins and quantitates their relative affinities. We have applied this in vitro technique to PRDM9, the zinc-finger protein that activates genetic recombination, obtaining new information on the regulation of hotspots, whose locations and activities determine the recombination landscape. We identified 31,770 binding sites in the mouse genome for the PRDM9(Dom2) variant. Comparing these results with hotspot usage in vivo, we find that less than half of potential PRDM9 binding sites are utilized in vivo. We show that hotspot usage is increased in actively transcribed genes and decreased in genomic regions containing H3K9me2/3 histone marks or bound to the nuclear lamina.

conclusionsThese results show that a major factor determining whether a binding site will become an active hotspot and what its activity will be are constraints imposed by prior chromatin modifications on the ability of PRDM9 to bind to DNA in vivo. These constraints lead to the presence of long genomic regions depleted of recombination.

Identifiers

PMID26351520
PMCPMC4562113
OpenAlexW1755642556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.